Latest News About - Gastroenterology and urology devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Wednesday, January 23, 2019

5:59:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

David M Reese said: "We are pleased with the Committee's recommendation to approve EVENITY for the treatment of postmenopausal women with osteoporosis at high risk for fracture," External link

marketwatch Wednesday, January 16, 2019 11:49:00 PM CET

Pascale Richetta said: "Evidence suggests that many women who sustain a fragility fracture are not appropriately treated for osteoporosis. This is why new treatment options, like EVENITY, are so important," External link

marketwatch Wednesday, January 16, 2019 11:49:00 PM CET

Tony Hall says: "Partnering with one prime vendor across our entire supply chain, particularly where our academic campuses and MU Health Care intersect, helps our entire system collaborate as a single unit," External link

markets-businessinsider Monday, January 14, 2019 5:52:00 PM CET

Rafael Coelho said: "Prostate cancer has historically been aggressively treated with radiotherapy or open prostatectomy that, in many cases, overtreats earlier stages of disease and carries life-altering side effects. In contrast, Focal One represents a targeted, less invasive and personalized approach that can produce improved outcomes for select patients depending on their stage of disease," External link

euroinvestor Monday, January 14, 2019 2:19:00 PM CET

David McNally said: “I extend congratulations to Dr. Perry Genova, our Senior Vice President of Research and Development, and our engineering team for achieving this significant development milestone on an aggressive schedule during the fourth quarter of 2018,” External link

4-traders Thursday, January 3, 2019 2:58:00 PM CET

David McNally commented: “The granting of these patents and those pending issuance further strengthen Titan’s position as a leader in single-port robotic surgery technology,” External link

4-traders Monday, December 17, 2018 2:43:00 PM CET

Michael Hoey said: “This investment will support additional international clinical work, followed by a US IDE pilot study in late 2019,” External link

marketwatch Thursday, December 13, 2018 3:31:00 PM CET

Michael Hoey said: “Based on the success of initial clinical trials, we are confident that cancer ablation by water vapor will be an effective, next-generation treatment for prostate cancer without the unwanted side effects of urinary incontinence and erectile dysfunction which are associated with radical prostatectomies,” “We foresee this technology as a true minimally invasive breakthrough that will improve quality of life and expand the cancer treatment options available today for patients suffering from prostate, bladder and kidney cancers” External link

marketwatch Thursday, December 13, 2018 3:31:00 PM CET

Martin Frost said: “We are pleased to partner with the Nicholson Center to roll out a training program that introduces surgeons to Versius. Versius has been designed with the surgeon in mind and we are confident that by supporting the necessary training we can work with surgeons to realize the benefits of minimal access surgery for patients,” External link

euroinvestor Wednesday, December 12, 2018 3:25:00 PM CET

Roger Smith said: “The Nicholson Center’s goal is to continue offering surgeons the ability to train on the latest and most advanced medical technology, and CMR Surgical’s Versius fits the bill,” External link

euroinvestor Wednesday, December 12, 2018 3:25:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.